Accession Number: | 0000899243-21-014967 |
Date: | 2021-04-01 |
Issuer: | COGENT BIOSCIENCES, INC. (COGT) |
Original Submission Date: |
ROS MATTHEW
C/O COGENT BIOSCIENCES, INC.
200 CAMBRIDGE PARK DRIVE, SUITE 2500
CAMBRIDGE, MA 02140
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 9.08 | 2021-04-01 | deemed execution date | A | 2,068 (a) | 2031-04-01 | common stock 2,068 | $9.08 | 2,068 | direct |
ID | footnote |
---|---|
f1 | the option award was issued to the reporting person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the issuer's non-employee director compensation plan. the number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the black-scholes value of a single option calculated as of the date of the grant. |
f2 | this option is fully vested at time of grant. |